Cannabinodiol (CBND), also known as cannabidinodiol,[1] cannabinoid that is present in the plant Cannabis sativa at low concentrations.[2] It is the fully aromatized derivative of cannabidiol (CBD) and can occur as a product of the photochemical conversion of cannabinol (CBN).[3]

Cannabinodiol
Clinical data
ATC code
  • None
Legal status
Legal status
Identifiers
  • 5'-Methyl-4-pentyl-2'-(prop-1-en-2-yl)-[1,1'-biphenyl]-2,6-diol
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC21H26O2
Molar mass310.437 g·mol−1
3D model (JSmol)
  • CCCCCC1=CC(=C(C(=C1)O)C2=C(C=CC(=C2)C)C(=C)C)O
  • InChI=1S/C21H26O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h9-13,22-23H,2,5-8H2,1,3-4H3
  • Key:TWKHUZXSTKISQC-UHFFFAOYSA-N

See also

edit

References

edit
  1. ^ US 9084771, McAllister SD, Desprez PY, "Methods and compositions for treating cancer", published 21 July 2015, assigned to Sutter West Bay Hospitals 
  2. ^ Ch Lousberg RJ, Bercht CL, van Ooyen R, Spronck HJ (1 January 1977). "Cannabinodiol: Conclusive identification and synthesis of a new cannabinoid from Cannabis sativa". Phytochemistry. 16 (5): 595–597. Bibcode:1977PChem..16..595R. doi:10.1016/0031-9422(77)80023-X.
  3. ^ Elsohly MA, Slade D (December 2005). "Chemical constituents of marijuana: the complex mixture of natural cannabinoids". Life Sciences. Natureceuticals (Natural Products), Nutraceuticals, Herbal Botanicals, and Psychoactives: Drug Discovery and Drug-Drug Interactions; Volume I: Natureceuticals (Natural Products), Herbal Botanicals, Psychoactive Hallucinogens and Related Products. 78 (5): 539–548. doi:10.1016/j.lfs.2005.09.011. PMID 16199061.